Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |